background: Elevated serum progesterone levels at the end of the follicular phase in controlled ovarian stimulation (COS) leads to a poorer ongoing pregnancy rate in IVF cycles due to reduced endometrial receptivity. The objective of this study was to use microarray technology to compare endometrial gene expression profiles at the window of implantation according to the levels of circulating progesterone.
Introduction
Embryo implantation continues to be the most uncertain event of the whole reproductive process. Among the diverse factors affecting its prognosis, elevation of circulating progesterone levels at the end of the follicular phase in controlled ovarian stimulation (COS) for IVF-embryo transfer seems to have a negative impact on embryo implantation and therefore on cycle outcome (Schoolcraft et al., 1991; Silverberg et al., 1991; Mio et al., 1992; Check et al., 1993; Fanchin et al., 1993 , Harada et al., 1995 , Randall et al., 1996 Shulman et al., 1996; Fanchin et al., 1997; Bosch et al., 2003; Kiliçdag et al; . In fact, it has been recently reported that serum progesterone levels .1.5 ng/ml on the last day of COS are related to a significant decrease in the ongoing pregnancy rate following IVF cycles, irrespective of the gonadotrophin-releasing hormone (GnRH) analogue used for pituitary down-regulation (Bosch et al., 2010) .
Although the mechanism by which increased serum progesterone concentrations affect cycle outcome is still unclear, some data suggest that it impair endometrial receptivity rather than oocyte quality (Fanchin et al., 1996; Fanchin et al., 1997; Fanchin et al., 1999; Smitz et al., 2007) . Both the oocyte donation and embryo cryopreservation models are the best clinical tools to distinguish the effects on oocytes from those on the endometrium. Elevated progesterone in donors has been found to have no adverse effect on oocyte quality and the implantation rate in recipients (Hofmann et al., 1993; Legro et al., 1993; Check et al., 1994; Shulman et al., 1996; Melo et al., 2006; Check et al., 2010) , thus corroborating that the putative adverse impact of progesterone in IVF is likely to be on the endometrium (Chetkowski et al., 1997; Fanchin et al., 1997; Shapiro et al., 2010) .
Some authors have suggested that the mechanism underlying the deleterious effect of an elevated progesterone level is an abnormally accelerated endometrial maturation leading to impaired endometrial receptivity (Forman et al., 1989; Sharma et al., 1990; Silverberg et al., 1991; Melo et al., 2006) . This secretory endometrial transformation has been observed on the day of oocyte retrieval in both the GnRH agonist (Chetkowski et al., 1997; Ubaldi et al., 1997) and antagonist cycles (Kolibianakis et al., 2002; Van Vaerenbergh et al., 2009) .
Furthermore, immunohistochemistry assays have shown that estrogen receptor and progesterone receptor expression in the endometrium on the day of human chorionic gonadotrophin (hCG) administration is similar to that described on the first days of the luteal phase in natural cycles. This indicates an accentuated maturation of the endometrium exposed to supraphysiological concentrations of progesterone in the late follicular phase of IVF cycles (Papanikolaou et al., 2005) . This endometrial advancement anticipates the window of implantation, which is a self-limited period, in which the endometrial epithelium acquires a functional ability to support blastocyst adhesion (Horcajadas et al., 2006) .
There are several studies that have focused on the gene profile of the endometrium during the window of implantation. By comparing gene expression in three different situations: (i) the natural cycle (Riesewijk et al., 2003) , (ii) the IVF-stimulated cycle and (iii) non-receptive conditions, such as insertion of an intrauterine device (Horcajadas et al., 2006) , we were able to find 25 genes that seem relevant during the window of implantation . In this work, we investigate endometrial gene expression during the peri-implantation period in young women under COS in accordance with the presence or absence of high circulating progesterone levels at the end of the follicular phase.
Materials and Methods

Study design
This was a single-centre, prospective cohort study carried out in a university-affiliated private infertility clinic between April 2007 and July 2009. Twelve women were included in the study, which was designed to compare the gene expression profile in the endometrium between two groups: (i) study group (six women) with a progesterone serum level of .1.5 ng/ml and (ii) control group (six women) with a progesterone serum level of ,1.5 ng/ml on the day of recombinant chorionic gonadotrophin (rCG) administration. Each group included three cases under a GnRH agonist long protocol and three others under a GnRH antagonist multiple-dose protocol for pituitary down-regulation. The cut-off level of 1.5 ng/ml was chosen in accordance with our most recent published results which confirm that a progesterone serum level surpassing this threshold is detrimental for cycle outcome (Bosch et al., 2010) .
The primary end-point was to analyse the impact of high progesterone levels on the last day of COS on the gene expression profile of the endometrium during the window of implantation.
The Institutional Review Board's and the Institution's Ethics Committee approvals were obtained. The clinicaltrials.gov registration number is NCT00447850.
Study population and protocol
A total of 12 young and healthy women (oocyte donors) were enrolled in the study. Inclusion criteria were: (i) age between 18 and 35 years; (ii) regular menstrual cycle (25 -35 days); (iii) normal cycle day 3 hormones (FSH ,10 IU/L; LH ,10 IU/L and E 2 ,60 pg/ml; (iv) body mass index (BMI) between 18 and 25 kg/m 2 and (v) normal karyotype. Exclusion criteria were: (i) endometriosis and (ii) polycystic ovary syndrome. Donors underwent COS using either a GnRH agonist long protocol (Procrinw, Abbot, Madrid, Spain) or a GnRH antagonist multiple-dose protocol (Cetrotidew, Merck-Serono, Geneva, Switzerland) for pituitary suppression. Ovarian stimulation was carried out with a fixed starting dose of 225 IU/day s.c. of recombinant follicle-stimulating hormone (rFSH) (Gonal-Fw, Merck-Serono, Geneva, Switzerland) for the first 3 days of stimulation, when doses were adjusted according to the ovarian response.
Ovulation induction was performed with rCG, 250 mg, s.c. (Ovitrellew, Merck-Serono, Geneva, Switzerland) when at least three follicles reached 18 mm in diameter, and oocyte retrieval was carried out 36 h later by a transvaginal ultrasound-guided puncture of follicles. Serum oestradiol (E 2 ) and progesterone levels were determined on the day of rCG administration. The luteal phase of the oocyte donor was supplemented with a vaginal administration of 400 mg/day of natural micronized progesterone (Progeffikw, Effik, Madrid, Spain), starting 1 day after oocyte retrieval in order to simulate a patient's cycle in which an embryo transfer is performed after COS. All the donors gave their written informed consent.
Progesterone measurement
Serum progesterone levels were measured on the day of rCG administration. Samples were tested with a microparticle enzyme immunoassay Axsym System (Abbott Cientifica S.A., Madrid, Spain), which had a sensitivity of 0.2 ng/ml. Intraobserver and interobserver variation coefficients were 9.6 and 3.9%, respectively. As previously described, besides the internal quality control checks performed daily in the institution's laboratory, assays were calibrated whenever a new reactive batch was used or whenever an outcome outside the normal range was observed. Furthermore, external quality control assessment of every hormone assay was performed monthly at the Spanish Society of Clinical Biochemistry and Molecular Pathology, as previously reported (Bosch et al., 2010) .
Tissue collection
A total of 12 endometrial samples were collected using a Pipelle catheter (Pipelle de Cornierw, Prodimed, Neuilly-en-Thelle, France) under sterile conditions from the uterine fundus. The biopsy was performed 7 days after the rCG injection (rCG + 7) as it is considered the window of implantation. Endometrial dating was performed using Noyes' criteria (Noyes et al., 1950) by a pathologist who was blind to the day on which the specimen was obtained.
RNA isolation
A portion (one half) of each sample was snap frozen in liquid nitrogen and stored at2708C until further processing. Total RNA was extracted using the 'Trizol method' according to the protocol recommended by the manufacturer (Life Technologies, Inc., Gaithersburg, MD, USA). In short, homogenized biopsies (1 ml TRIzol reagent/75 mg tissue) were incubated at room temperature for 5 min, chloroform (0.2 volumes of TRIzol) was then added and samples were incubated for 2.5 min at room temperature. Thereafter, the aforementioned samples were centrifuged for 15 min at 12 000 g (48C). The aqueous phase was precipitated with an equal volume of 2-propanol, stored in ice for 5 min and centrifuged for 30 min at 12 000 g (48C). The pellet was washed with 75% ethanol and dissolved in DEPC-treated water. The integrity of the RNA samples (RNA quality control procedure) was assessed with the 2100 Bioanalyzer (Agilent Technologies, Madrid, Spain) by running an aliquot of the RNA samples in the RNA 6000 Nano LabChip (Agilent Technologies, Madrid, Spain).
Microarray hybridization
All samples were hybridized in the Whole Human Genome Oligo Microarray (Agilent Technologies, Madrid, Spain) that encompasses more than 44 000 human DNA probes. The sample preparation and hybridization protocols to be followed with the endometrial samples were adapted from the Agilent Technical Manual. In short, first-strand cDNA was transcribed from 1 mg of total RNA using the T7-Oligo(dT) Promotor Primer. Samples were in vitro transcribed and Cy-3 labelled [all with the Quick-AMP labelling kit (Agilent Technologies, Madrid, Spain)]. The cRNA synthesis typically yielded between 10 and 15 mg. Following a further clean-up round (QIAGEN, Barcelona, Spain), cRNA was fragmented into pieces ranging from 35 to 200 bases that were confirmed using the Agilent 2100 Bioanalyzer technology. Fragmented cRNA samples (1.65 mg) were hybridized onto chips by means of a 17-h of incubation at 658C with constant rotation, then microarrays were washed in 2 × 1-min steps in two washing buffers (Agilent Technologies, Madrid, Spain). Hybridized microarrays were scanned in an Axon 4100A scanner (Molecular Devices, Sunnyvale, CA, USA), and data were extracted with the GenePix Pro 6.0 software (Molecular Devices, Sunnyvale, CA, USA).
Data processing and data analysis
The GenePix Pro 6.0 software was used for array image analysis and the calculation of spot intensity measurements, which are considered raw data.
Spot intensities (medians) without background subtraction were transformed to the log 2 scale. Before quantile normalization, the data were represented on a box plot to know data distribution and to subtract any abnormal microarray data. The replicates by gene symbol were merged and the data were filtered in order to delete the unknown sequences or probes without a gene description.
The R-statistical software system was used as a tool for these purposes and for the downstream analysis (R Development Core Team, 2004) .
The gene expression profile was determined by comparing the experimental groups with the control group (2-by-2 comparisons) with parametric tests (Significance Analysis of Microarrays (SAM)) and non-parametric tests (Rank Product). Two criteria were used to define the genes that had altered mRNA abundance among the different sample sets: an absolute fold change of 2.0 or more and a corresponding corrected P-value ,0.05.
Functional analysis of the results
To detect activations or inactivations in biological functions or pathways, we used the database for annotation, visualization and integrated discovery (DAVID) (Dennis et al., 2003) , a gene-set based algorithm that detects the significant representation of functionally related genes in lists of genes ordered by differential expression. DAVID can search blocks of functionally related genes by different criteria such as Gene Ontology (GO) terms, KEGG pathways and others.
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (von Mering et al., 2007) then represents the connections among the differentially expressed genes.
Clustering and principal component analysis
The expression data were normalized by Z-score. Hierarchical clustering was performed with the MeV 4.2.02 software (http://www.tm4.org) (Saeed et al., 2003) with a complete-linkage hierarchical clustering algorithm to be then visualized by the same software. Euclidean distance was chosen as the similarity measure.
A principal component analysis (PCA) was performed using the MeV 4.2.02 software. The data table of rows (genes) and columns (endometrial samples) was transposed and a PCA was run to reduce the number of variables to two or three principal components, which represent the majority of data set variability. A two-or three-dimensional scatterplot was produced to visualize the differences in sample sets based on each sample's gene expression profile. Table I summarizes the baseline characteristics and ovarian stimulation parameters of all 12 women. The mean age of patients who participated in the study was 24.7 + 4.3 years. There was a significant difference in the mean age of women from the study group when compared with the control group (27.5 + 4.2 versus 22 + 2.2 years, respectively, P ¼ 0.017). The progesterone serum levels on the last day of COS were significantly higher in the study group (2.39 + 0.8 versus 0.54 + 0.2 ng/ml, respectively).
Results
Regarding embryo quality, the mean number of blastomeres of the whole embryo cohort on cleavage Day 3 was 7.43 + 0.73 in the control group and 7.38 + 0.65 for the study group (P ¼ 0.87), while fragmentation rates were 5.89 + 3.32 and 11.22 + 5.56, respectively (P ¼ 0.007). The clinical pregnancy rate was 57.1% in patients who received oocytes from donors with P ,1.5 ng/ml on the day 
Table I
Oocyte donor parameters according to P levels on the day of rCG administration. P level <1.5 ng/ml (n 5 6) P level > 1.5 ng/ml (n 5 6) Data are expressed as mean (+SD) or percentage; P, progesterone; E2, estradiol; rCG, recombinant chorionic gonadotrophin. P-value represents the significance value of the studied comparison; P , 0.05 ¼ significant.
P-value
Endometrial receptivity and serum progesterone levels of rCG administration, and 46.7% in those whose donors showing P . 1.5 ng/ml (P ¼ 0.58; OR ¼ 0.66 (CI: 0.15 -2.84).
Histological endometrial dating
According to Noyes' criteria, the histological dating of the endometrium on day rCG + 7 in the study group showed no significant (P ¼ 0.628) advancement in dating (10.0 + 1.7, mean of days after ovulation + SD) compared with the control group (9.3 + 2.8).
Differential gene expression
After RNA isolation, all the samples were of good enough quality to be included in the microarray experiments. In all, 12 endometrial samples were analysed, as was the normalized data used for further bioinformatics analyses. To find differentially expressed genes, two different methods were used: parametric (SAM) and non-parametric (Rank product). Using SAM, 140 genes were found to be differentially expressed between the two groups (64 up-and 76 down-regulated genes) using a fold change .2 and a corrected P-value ,0.05. Using Rank product, the number of dysregulated genes were 161 up-and 209 down-regulated in the higher progesterone level group. The differentially expressed genes found with SAM are listed in Table II . Gene symbol, gene description, fold change and percentage of false discovered rate (FDR) are indicated for the parametric dysregulated genes. Finally, we compared the list of dysregulated genes in women with high circulating progesterone levels with the 25 window of implantation genes strongly related to receptiveness and the implantation process . These genes are regulated in the natural cycle in one sense, showing a dysregulation under subfertile conditions, and stimulated cycles Simón et al., 2005; Horcajadas et al., 2008a) or refractory situations in the presence of an intrauterine device (Horcajadas et al., 2006) . Of these 25 genes, 13 showed a dysregulation in women with high progesterone levels: 7 were over up-regulated and 6 were over-down-regulated. All these genes showed higher changes than those observed in the normal natural cycle. Those genes, which appeared up-regulated in the natural cycle, were more markedly up-regulated in women who had high progesterone levels. On the other hand, those genes which were down-regulated in the normal natural cycles were observed to be more down-regulated in women with high progesterone levels. Furthermore, 8 of these 13 genes were seen to have putative progesterone response elements (PRE) (DNA-binding sites, AACAGT) in their regulatory sequences. This search was performed on the PROMO Home Page, a virtual laboratory for the identification of putative transcription factor-binding sites in DNA sequences (http://alggen.lsi.upc.es/cgibin/promo_v3/ promo/promoinit.cgi?dirDB=TF_8.3). The list of these 25 genes analysed in this part is shown in Table III . Their regulation in natural cycle and their dysregulation under suboptimal receptive conditions, their over-expression with high level of progesterone and the number of PREs are also indicated. Over-expressed genes are highlighted in bold.
Sample clustering
Using the expression of all the genes and PCA, those samples belonging to the same group tended to be in the same cluster (data not shown). Using the 140 differentially expressed genes and PCA, we distinguished two clear groups (data not shown). We also performed hierarchical clustering by using Pearson' correlation, and samples were classified into two main groups: one containing all the control samples and the other containing the high progesterone level samples (Figure 1) .
GO of the differentially expressed genes
Using the GO implemented in DAVID, we investigated the biological sense of the 140 dysregulated genes. We analysed the biological processes, cellular component, molecular functions and KEGG pathways. We discovered several biological over-represented processes with statistical significance (FDR ,0.05). These over-represented biological processes were mainly related to cell adhesion, developmental process, immune system process and others (see Table IV ). The cellular components and molecular functions pathways were statistically and significantly over-represented, and they are also summarized in Table IV . Finally, only one KEGG pathway was over-represented with statistical significance for antigen processing and presentation.
Discussion
Despite the wide use of GnRH analogues for pituitary down-regulation in COS cycles for IVF, subtle increases in serum progesterone levels are still observed at the end of the follicular phase in many cases (Edelstein et al., 1990; Silverberg et al., 1991; Ubaldi et al., 1996; Bosch et al., 2003; Papanikolaou et al., 2009; Bosch et al., 2010) .
The clinical impact of this has been highly controversial for a good many years, with some studies that could not find any association between progesterone levels and pregnancy rates (Givens et al., 1994; Bustillo et al., 1995; Levy et al., 1995; Ubaldi et al., 1995; Abuzeid and Sasy, 1996; Doldi et al., 1999; Venetis et al., 2007) , whereas others have reported a negative impact on cycle outcome when serum progesterone levels are increased on the day of hCG administration (Check et al., 1993 , Fanchin et al., 1993 Harada et al., 1995; Shulman et al., 1996; Bosch et al., 2003) . Nevertheless, we recently showed with a sample of more than 4000 IVF cycles that a serum progesterone level above the threshold of 1.5 ng/ml on the last day of COS is related to a significant decrease in the ongoing pregnancy rate in all types of patients and in any circumstances related to ovarian response (Bosch et al., 2010) . It must be taken into consideration that the majority of studies that failed to demonstrate an association between serum progesterone levels and pregnancy rate used a threshold value of 0.9 ng/ml, which was mostly chosen arbitrarily without performing a trend analysis to identify an association between progesterone levels and pregnancy (Bosch, 2008) .
To ascertain whether these negative results are a consequence of impairment in endometrial receptiveness, we conducted the present study in which the gene expression of endometria of young healthy women (oocyte donors), under COS with rFSH and pituitary suppression, has been analysed according to the serum progesterone levels (, or .1.5 ng/ml) on the day of rCG administration. To the best of our knowledge, this is the first study to analyse the impact of progesterone levels on the gene expression profile of the endometrium in the window of implantation period because to date, the impact of supraphysiological levels of progesterone on the endometrium has 
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Endometrial receptivity and serum progesterone levels been studied by means of histological and immunohistochemical changes, but not by gene expression profiling. The present study shows, by using parametric and non-parametric methods, that a total of 140 and 370 genes, respectively, are dysregulated by more than 2-fold in women with high serum progesterone levels. The biological processes over-represented in a large number of these genes (cell adhesion, immune system, organ development) could affect the endometrium and the implantation process.
When compared with the list of key genes that could be relevant for the previously described endometrial receptivity , we found that the RNA levels of 13 of these 25 genes presented an over-expression in women with high progesterone levels (Table III) . Excepting the FOLR1 gene, the other 12 genes are the gene targets included in the endometrial receptivity array, a genomic tool recently published and used for endometrial receptivity evaluation (Díaz-Gimeno et al., 2011). The over-regulation of eight of these genes can be explained directly by high progesterone levels because they contain putative PRE in their regulatory sequences (Table III) . However, there are three genes (FXYD2, LIF and CNN1) that were not over-regulated in the high progesterone group, although putative PRE were detected (Table III) .
The impact of high progesterone levels on the endometrium can have a double effect: on the one hand, directly induced by the action of progesterone on the gene expression via its own receptor and, on the other hand, the secondary effects that are downstream of the progesterone receptor cascade, such as the activation/repression of other regulatory proteins like the E 2 receptor, which modulates its action in uterine target cells, leading to an heterologous desensitization to E 2 (Bayard et al., 1978) .
A recent study showed that in IVF-stimulated cycles, endometrial gene expression on the day of oocyte retrieval discriminates between women with and without histologically advanced endometrial maturation exceeding 3 days (Van Vaerenbergh et al., 2009) . Thus, both mechanisms seem to be closely related at that period. Nevertheless, our data reflect that histological endometrial dating is not related to the gene expression profile of the endometrium during the window of implantation as no significant differences in endometrial advancement were observed between the two study groups. One possible explanation for this finding is that Noyes' criteria are less accurate than originally described due to high intersubject, intrasubject and interobserver variability (Murray et al., 2004 ). This indicates a questionable relationship to endometrial receptivity (Murray et al., 2002) when compared with the gene expression assessment which, according to our present data, seems to be further related to the impact of progesterone in the clinical outcome.
It is of interest to note that when endometrial advancement becomes extreme (.3 days as compared with the expected chronological date) on the day of hCG administration, no clinical pregnancies are obtained when the embryo transfer is performed on Day 3 (Ubaldi et al., 1997; Kolibianakis et al., 2002; Van Vaerenbergh et al., 2009 ). This is due to an early closure of the window of implantation (Papanikolaou et al., 2005 ) that disturbs the cross-dialogue between embryo and endometrium. Conversely, these endometrial changes on the hCG day do not exert a detrimental effect when the transfer is delayed until the blastocyst stage. What this implies is that, from the histological viewpoint, the endometrium could recover during the window of implantation period from the violation induced by supraphysiologic steroid concentrations (Papanikolaou et al., 2009) . In natural cycles, such an advancement in endometrial maturation is not present , and suggests that high levels of steroid hormones during COS induce secretory changes in the endometrium. It has been postulated that high E 2 levels mediate an earlier expression of the progesterone receptors in the early follicular phase, leading to an advancement of the endometrium in the late follicular phase even with normal progesterone levels at this time (Marchini et al., 1991) . Moreover, the higher the E 2 levels are, the higher the progesterone levels are; thus, they usually come together when the ovarian response is greater than expected (Bosch et al., 2003; Venetis et al., 2007; Bosch et al., 2010) .
It is difficult to depict between the negative effects of both ovarian steroid hormones when they are at supraphysiological levels during COS (Valbuena et al., 1999; Martínez-Conejero et al., 2007; Chen et al., 2008; van der Gaast et al., 2009) . In the present study, E 2 levels on day of rCG administration were not a confounding factor as the levels in both groups did not differ significantly, although there was a huge difference between the groups in terms of progesterone levels. Moreover, we have previously shown that, regardless of the E 2 levels, progesterone exerts a deleterious effect on cycle outcome (Bosch et al., 2010) . On the other hand, E 2 levels seem to affect the embryo more negatively than the endometrium (Valbuena et al., 2001) , whereas progesterone seems to be more detrimental to the endometrium, according to the present data. Women from the study group were significantly younger than the control group. This could explain the higher ovarian response observed in terms of number of oocytes and steroid hormone levels, although these differences were not statistically significant. Age should not be considered as a confounding factor, as endometrial receptivity might depend on the supraphysiological levels of ovarian steroid hormones (Chen et al., 2007 (Chen et al., , 2008 but not on the age, except for cases of very advanced maternal age (Soares et al., 2005) . It is interesting to note that the study group received higher doses of recombinant FSH, although they had similar BMI. The association between doses of FSH and increase of progesterone levels on hCG day has been previously described (Filicori et al., 2002; Bosch et al., 2010) .
The oocyte donation model has proved a most useful tool to distinguish between the effects of high progesterone levels on the oocyte from those on the endometrium. A previous clinical study by our group (Melo et al., 2006) compared the outcome of two consecutive oocyte donation cycles in the same donor in accordance with the presence or absence of high serum progesterone levels on the day of hCG administration. No differences were found in terms of embryo The genes of the present study are in column P4 with their P-values and the corrected P-value (FDR). Over-expressed genes are highlighted in bold. The last column is the number of progesterone responsible elements (PRE) in the promoter region of the genes. quality between both cycles, which indicates that an increase in progesterone does not affect oocyte quality. Clinical pregnancy rates in oocyte recipients were not affected as the endometrium was not exposed to high progesterone levels.
In the present study, we also used the oocyte donation model as this offers the advantage of performing an endometrial biopsy during the window of implantation. Otherwise, if the study had been carried out in patients undergoing IVF-embryo transfer, a fresh embryo transfer could not have been performed as an endometrium biopsy at the time of the window of implantation could have proved hazardous for embryo implantation. To mimic the endometrial status of a patient undergoing IVF treatment, oocyte donors received the same doses of natural micronized progesterone as patients do in a conventional cycle with their own oocytes. With this approach, we were able to do an in-depth analysis of the events taking place in the receptive phase as they are determining factor for the IVF cycle to be a success. In the current study, no significant differences in terms of the clinical pregnancy rate and the mean number of blastomeres between both study groups were observed. Although the fragmentation rate was significantly higher in the group with P . 1.5 ng/ ml, it remained below 20% in both groups. In any event, the study design does not allow a comparison to be made of the clinical outcome between both groups given the low number of patients included.
Previously, we focused on several works using microarray technology in terms of gene expression profiling of the human endometrium in the receptive phase in different situations (Riesewijk et al., 2003; Horcajadas et al., 2004a,b; Horcajadas et al., 2005; Horcajadas et al., 2006; Horcajadas et al., 2008b) to show that COS affects the global gene expression profiling across the window of implantation Categories are BP, biological processes; CC, cellular components. The % represents the genes relating to the term by taking into account the total of dysregulated genes. FDR is false discovery rate.
when compared with the natural cycle. This could explain how, despite advances in IVF procedures, implantation rates remain lower than we desire, suggesting that the endometrium in COS cycles does not reach the receptive status in the same manner as in natural cycles (Horcajadas et al., 2008a) . In the present study, we demonstrate that the gene expression profiles of the endometrium samples obtained from women with elevated progesterone levels (.1.5 ng/ml) at the end of the follicular phase under a COS treatment differ substantially from those obtained from women with normal progesterone levels, even though both were collected at the window of implantation (rCG + 7).These findings prove that the concept of the poorer outcome of IVF cycles when progesterone is high on the day of rCG administration is due to impaired endometrial receptivity, leading to a lower implantation rate, as previously suggested by other authors (Hofmann et al., 1993; Check et al., 1994; Shulman et al., 1996; Chetkowski et al., 1997; Fanchin et al., 1997; Smitz et al., 2007; Kyrou et al., 2009 ). According to this concept, it is highly valuable to monitor serum progesterone levels in COS for IVF, especially at the end of the follicular phase. In the event of increased values, cryopreservation of all the obtained embryos and their subsequent transfer in a natural cycle is recommended as the clinical guideline.
